C30 compound,
LDN 57444,
LDN-57444,
LDN57444,
LDN-57444,
668467-91-2,
UCH-L1 Inhibitor,
Ubiquitin Thiolesterase L1 Inhibitor,
Ubiquitin C-Terminal Esterase L1 Inhibitor,
Ubiquitin C-Terminal Hydrolase L1 Inhibitor,
C17H11Cl3N2O3,
(Z)-3-(acetoxyimino)-5-chloro-1-(2,5-dichlorobenzyl)indolin-2-one,
3-(O-acetyloxime), 5-chloro-1-[(2,5-dichlorophenyl)methyl]-1H-Indole-2,3-dione,
5-Chloro-1-[(2,5-dichlorophenyl)methyl]-1H-indole-2,3-dione 3-(O-acetyloxime),
CHEMBL3407553,
SCHEMBL16249746,
BDBM65518,
AOB1095,
EX-A700,
2511AH,
MFCD09037562,
ZINC83434034,
AKOS025295611,
CS-3923,
NCGC00247668-01,
BC600330,
HY-18637,
SW219408-1,
LDN-57444, >=98% (HPLC),
[(E)-[5-Chloro-1-[(2,5-dichlorophenyl)methyl]-2-oxoindol-3-ylidene]amino] acetate,
Ceritinib (LDK378),
LDN 57444,
1H-Indole-2,3-dione, 5-chloro-1-[(2,5-dichlorophenyl)methyl]-, 3-(O-acetyloxime),
C30,